胆道障害治療の世界市場:規模・現状・予測2019-2025

【英語タイトル】Global Biliary Tract Disorder Treatment Market Size, Status and Forecast 2019-2025

QYResearchが出版した調査資料(QYR20FB13167)・商品コード:QYR20FB13167
・発行会社(調査会社):QYResearch
・発行日:2019年12月
・ページ数:92
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥413,400見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥620,100見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥826,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※当調査レポートでは、胆道障害治療の世界市場について調査・分析し、胆道障害治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(医薬品、外科、その他)、用途別(病院、診療所、その他)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界の胆道障害治療市場動向
・主要企業別マーケットシェア
・胆道障害治療の種類別市場規模2014-2019
(医薬品、外科、その他)
・胆道障害治療の用途別市場規模2014-2019
(病院、診療所、その他)
・胆道障害治療の北米市場:主要企業・種類別/用途別市場規模
・胆道障害治療のヨーロッパ市場:主要企業・種類別/用途別市場規模
・胆道障害治療の中国市場:主要企業・種類別/用途別市場規模
・胆道障害治療の日本国内市場:主要企業・種類別/用途別市場規模
・胆道障害治療の東南アジア市場:主要企業・種類別/用途別市場規模
・胆道障害治療のインド市場:主要企業・種類別/用途別市場規模
・胆道障害治療の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(AstraZeneca、Asklepion Pharmaceuticals、Intuitive Surgical、Merck、Abbott Laboratories、Boston Scientific、Conmed、Cook Medical、B. Braun Melsungen、Medtronic、Terumo、Merit Medical、Olympus、Becton Dickinson)
・胆道障害治療の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Biliary Tract Disorder Treatment is treatments that used to treat biliary diseases. Biliary disease refers to diseases affecting the bile ducts, gallbladder and other structures involved in the production and transportation of bile.In 2018, the global Biliary Tract Disorder Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Biliary Tract Disorder Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Biliary Tract Disorder Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
AstraZeneca
Asklepion Pharmaceuticals
Intuitive Surgical
Merck
Abbott Laboratories
Boston Scientific
Conmed
Cook Medical
B. Braun Melsungen
Medtronic
Terumo
Merit Medical
Olympus
Becton Dickinson

Market segment by Type, the product can be split into
Mecine
Surgery
Other

Market segment by Application, split into
Hospitals
Clinics
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Biliary Tract Disorder Treatment status, future forecast, growth opportunity, key market and key players.
To present the Biliary Tract Disorder Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Biliary Tract Disorder Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Biliary Tract Disorder Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Mecine
1.4.3 Surgery
1.4.4 Other
1.5 Market by Application
1.5.1 Global Biliary Tract Disorder Treatment Market Share by Application (2019-2025)
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Biliary Tract Disorder Treatment Market Size
2.2 Biliary Tract Disorder Treatment Growth Trends by Regions
2.2.1 Biliary Tract Disorder Treatment Market Size by Regions (2019-2025)
2.2.2 Biliary Tract Disorder Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Biliary Tract Disorder Treatment Market Size by by Players
3.1.1 Global Biliary Tract Disorder Treatment Revenue by by Players (2014-2019)
3.1.2 Global Biliary Tract Disorder Treatment Revenue Market Share by by Players (2014-2019)
3.1.3 Global Biliary Tract Disorder Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Biliary Tract Disorder Treatment Key Players Head office and Area Served
3.3 Key Players Biliary Tract Disorder Treatment Product/Solution/Service
3.4 Date of Enter into Biliary Tract Disorder Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Biliary Tract Disorder Treatment Market Size by Type (2014-2019)
4.2 Global Biliary Tract Disorder Treatment Market Size by Application (2014-2019)

5 North America
5.1 North America Biliary Tract Disorder Treatment Market Size (2014-2019)
5.2 Biliary Tract Disorder Treatment Key Players in North America
5.3 North America Biliary Tract Disorder Treatment Market Size by Type
5.4 North America Biliary Tract Disorder Treatment Market Size by Application

6 Europe
6.1 Europe Biliary Tract Disorder Treatment Market Size (2014-2019)
6.2 Biliary Tract Disorder Treatment Key Players in Europe
6.3 Europe Biliary Tract Disorder Treatment Market Size by Type
6.4 Europe Biliary Tract Disorder Treatment Market Size by Application

7 China
7.1 China Biliary Tract Disorder Treatment Market Size (2014-2019)
7.2 Biliary Tract Disorder Treatment Key Players in China
7.3 China Biliary Tract Disorder Treatment Market Size by Type
7.4 China Biliary Tract Disorder Treatment Market Size by Application

8 Japan
8.1 Japan Biliary Tract Disorder Treatment Market Size (2014-2019)
8.2 Biliary Tract Disorder Treatment Key Players in Japan
8.3 Japan Biliary Tract Disorder Treatment Market Size by Type
8.4 Japan Biliary Tract Disorder Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Biliary Tract Disorder Treatment Market Size (2014-2019)
9.2 Biliary Tract Disorder Treatment Key Players in Southeast Asia
9.3 Southeast Asia Biliary Tract Disorder Treatment Market Size by Type
9.4 Southeast Asia Biliary Tract Disorder Treatment Market Size by Application

10 India
10.1 India Biliary Tract Disorder Treatment Market Size (2014-2019)
10.2 Biliary Tract Disorder Treatment Key Players in India
10.3 India Biliary Tract Disorder Treatment Market Size by Type
10.4 India Biliary Tract Disorder Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Biliary Tract Disorder Treatment Market Size (2014-2019)
11.2 Biliary Tract Disorder Treatment Key Players in Central & South America
11.3 Central & South America Biliary Tract Disorder Treatment Market Size by Type
11.4 Central & South America Biliary Tract Disorder Treatment Market Size by Application

12 International Players Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Company Details
12.1.2 Company Description and Business Overview
12.1.3 Biliary Tract Disorder Treatment Introduction
12.1.4 AstraZeneca Revenue in Biliary Tract Disorder Treatment Business (2014-2019))
12.1.5 AstraZeneca Recent Development
12.2 Asklepion Pharmaceuticals
12.2.1 Asklepion Pharmaceuticals Company Details
12.2.2 Company Description and Business Overview
12.2.3 Biliary Tract Disorder Treatment Introduction
12.2.4 Asklepion Pharmaceuticals Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.2.5 Asklepion Pharmaceuticals Recent Development
12.3 Intuitive Surgical
12.3.1 Intuitive Surgical Company Details
12.3.2 Company Description and Business Overview
12.3.3 Biliary Tract Disorder Treatment Introduction
12.3.4 Intuitive Surgical Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.3.5 Intuitive Surgical Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Biliary Tract Disorder Treatment Introduction
12.4.4 Merck Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Abbott Laboratories
12.5.1 Abbott Laboratories Company Details
12.5.2 Company Description and Business Overview
12.5.3 Biliary Tract Disorder Treatment Introduction
12.5.4 Abbott Laboratories Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.5.5 Abbott Laboratories Recent Development
12.6 Boston Scientific
12.6.1 Boston Scientific Company Details
12.6.2 Company Description and Business Overview
12.6.3 Biliary Tract Disorder Treatment Introduction
12.6.4 Boston Scientific Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.6.5 Boston Scientific Recent Development
12.7 Conmed
12.7.1 Conmed Company Details
12.7.2 Company Description and Business Overview
12.7.3 Biliary Tract Disorder Treatment Introduction
12.7.4 Conmed Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.7.5 Conmed Recent Development
12.8 Cook Medical
12.8.1 Cook Medical Company Details
12.8.2 Company Description and Business Overview
12.8.3 Biliary Tract Disorder Treatment Introduction
12.8.4 Cook Medical Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.8.5 Cook Medical Recent Development
12.9 B. Braun Melsungen
12.9.1 B. Braun Melsungen Company Details
12.9.2 Company Description and Business Overview
12.9.3 Biliary Tract Disorder Treatment Introduction
12.9.4 B. Braun Melsungen Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.9.5 B. Braun Melsungen Recent Development
12.10 Medtronic
12.10.1 Medtronic Company Details
12.10.2 Company Description and Business Overview
12.10.3 Biliary Tract Disorder Treatment Introduction
12.10.4 Medtronic Revenue in Biliary Tract Disorder Treatment Business (2014-2019)
12.10.5 Medtronic Recent Development
12.11 Terumo
12.12 Merit Medical
12.13 Olympus
12.14 Becton Dickinson

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details



【掲載企業】

AstraZeneca、Asklepion Pharmaceuticals、Intuitive Surgical、Merck、Abbott Laboratories、Boston Scientific、Conmed、Cook Medical、B. Braun Melsungen、Medtronic、Terumo、Merit Medical、Olympus、Becton Dickinson

★調査レポート[胆道障害治療の世界市場:規模・現状・予測2019-2025] (コード:QYR20FB13167)販売に関する免責事項を必ずご確認ください。
★調査レポート[胆道障害治療の世界市場:規模・現状・予測2019-2025]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆